Concepedia

Kevin McClintock

KM

Statistics

Publications

16

Citations

4.3K

H-Index

15

Active since

2005

Affiliations

Arbutus Biopharma (Canada)(Current)

Innovative Targeting Solutions (Canada)

University of Geneva

Kevin McClintock is an author at Arbutus Biopharma (Canada) specializing in rna interference, life sciences, and molecular biology.

ORCID

Publications per year

2005–2024

16

Publications

16

RNAi-mediated gene silencing in non-human primates

Tracy Zimmermann, Amy C. H. Lee, Akin Akinc et al. · Nature · 2006 · 1.3K citations

, , +8

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

Adam D. Judge, Vandana Sood, Janet R. Shaw et al. · Nature Biotechnology · 2005 · 1.3K citations

, , +16

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

Adam D. Judge, Marjorie Robbins, Iran Tavakoli et al. · Journal of Clinical Investigation · 2009 · 329 citations · Full text

, , +15

2′-O-methyl-modified RNAs Act as TLR7 Antagonists

Marjorie Robbins, Adam D. Judge, Lisa Yi Liang et al. · Molecular Therapy · 2007 · 325 citations · Full text

, , +17

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes

Adam D. Judge, Kevin McClintock, Janet R. Phelps et al. · Molecular Therapy · 2005 · 276 citations · Full text

, , +16

1–5 of 16